A challenge trial can streamline testing of hepatitis C vaccines - STAT
Price: $ 38.00
4.7(556)
With a cure for #hepatitisC in hand, now is the time to use challenge trials to test new vaccines to prevent this debilitating and even deadly disease.
In the era of rapid mRNA-based vaccines: Why is there no effective hepatitis C virus vaccine yet?
Diagnostics, Free Full-Text
A guide to vaccinology: from basic principles to new developments
Impact of COVID-19 on routine immunisation in South-East Asia and Western Pacific: Disruptions and solutions - The Lancet Regional Health – Western Pacific
Hepatology Clinical - 2022 - Journal of Gastroenterology and Hepatology - Wiley Online Library
Unvaccinated kids bear brunt of COVID-19, studies show - University of Mississippi Medical Center
Hepatitis B Vaccine Market Size – Trends Analysis, 2032
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
Barriers and facilitators to timely birth-dose vaccines in Kinshasa Province, the DRC: a qualitative study
Pathogens, Free Full-Text
Diagnostics, Free Full-Text
Viral Hepatitis Surveillance and Case Management - Hepatitis C
The Determining Effective Testing in Emergency Departments and Care Coordination on Treatment Outcomes (DETECT) for Hepatitis C (Hep C) Screening Trial: rationale and design of a multi-center pragmatic randomized clinical trial of
COVID-19 and vaccination in Latin America and the Caribbean: challenges, needs and opportunities
